BioMarin Pharmaceutical earnings (net income)
BioMarin Pharmaceutical (BMRN) earned a net income of $348.90 M in fiscal year 2025, −18.3% compared with the year before. Net profit margin: 10.8% of revenue.
Earnings 2025$348.90 M
Change−18.3%
World rank#964
Market cap$11.90 B
Net income by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $348.90 M | −18.3% |
| 2024 | $426.86 M | +155% |
| 2023 | $167.65 M | +18.4% |
| 2022 | $141.56 M | — |
Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.